Literature DB >> 22101223

A varying-coefficient method for analyzing longitudinal clinical trials data with nonignorable dropout.

Jeri E Forster1, Samantha MaWhinney, Erika L Ball, Diane Fairclough.   

Abstract

Dropout is common in longitudinal clinical trials and when the probability of dropout depends on unobserved outcomes even after conditioning on available data, it is considered missing not at random and therefore nonignorable. To address this problem, mixture models can be used to account for the relationship between a longitudinal outcome and dropout. We propose a Natural Spline Varying-coefficient mixture model (NSV), which is a straightforward extension of the parametric Conditional Linear Model (CLM). We assume that the outcome follows a varying-coefficient model conditional on a continuous dropout distribution. Natural cubic B-splines are used to allow the regression coefficients to semiparametrically depend on dropout and inference is therefore more robust. Additionally, this method is computationally stable and relatively simple to implement. We conduct simulation studies to evaluate performance and compare methodologies in settings where the longitudinal trajectories are linear and dropout time is observed for all individuals. Performance is assessed under conditions where model assumptions are both met and violated. In addition, we compare the NSV to the CLM and a standard random-effects model using an HIV/AIDS clinical trial with probable nonignorable dropout. The simulation studies suggest that the NSV is an improvement over the CLM when dropout has a nonlinear dependence on the outcome.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101223      PMCID: PMC3414213          DOI: 10.1016/j.cct.2011.11.009

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  5 in total

Review 1.  Handling drop-out in longitudinal studies.

Authors:  Joseph W Hogan; Jason Roy; Christina Korkontzelou
Journal:  Stat Med       Date:  2004-05-15       Impact factor: 2.373

2.  Mixtures of varying coefficient models for longitudinal data with discrete or continuous nonignorable dropout.

Authors:  Joseph W Hogan; Xihong Lin; Benjamin Herman
Journal:  Biometrics       Date:  2004-12       Impact factor: 2.571

3.  Estimation and comparison of changes in the presence of informative right censoring: conditional linear model.

Authors:  M C Wu; K R Bailey
Journal:  Biometrics       Date:  1989-09       Impact factor: 2.571

4.  Random-effects models for longitudinal data.

Authors:  N M Laird; J H Ware
Journal:  Biometrics       Date:  1982-12       Impact factor: 2.571

5.  Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party.

Authors:  J J Eron; S L Benoit; J Jemsek; R D MacArthur; J Santana; J B Quinn; D R Kuritzkes; M A Fallon; M Rubin
Journal:  N Engl J Med       Date:  1995-12-21       Impact factor: 91.245

  5 in total
  3 in total

1.  Accounting for dropout reason in longitudinal studies with nonignorable dropout.

Authors:  Camille M Moore; Samantha MaWhinney; Jeri E Forster; Nichole E Carlson; Amanda Allshouse; Xinshuo Wang; Jean-Pierre Routy; Brian Conway; Elizabeth Connick
Journal:  Stat Methods Med Res       Date:  2015-06-15       Impact factor: 3.021

2.  The High-Intensity Exercise Study to Attenuate Limitations and Train Habits in Older Adults With HIV (HEALTH): A Research Protocol.

Authors:  Vitor H F Oliveira; Kristine M Erlandson; Paul F Cook; Catherine Jankowski; Samantha MaWhinney; Sahera Dirajlal-Fargo; Leslie Knaub; Chao-Pin Hsiao; Christine Horvat Davey; Allison R Webel
Journal:  J Assoc Nurses AIDS Care       Date:  2022 Mar-Apr 01       Impact factor: 1.354

Review 3.  A Bayesian natural cubic B-spline varying coefficient method for non-ignorable dropout.

Authors:  Camille M Moore; Samantha MaWhinney; Nichole E Carlson; Sarah Kreidler
Journal:  BMC Med Res Methodol       Date:  2020-10-07       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.